May 04, 2021 / 10:30AM GMT
Operator
Ladies and gentlemen, good day, and welcome to the Q4 FY '21 Earnings Conference Call of Alembic Pharmaceuticals Limited. We have with us today on the call Mr. Pranav Amin, Managing Director; Mr. R.K. Baheti, Director Finance and CFO; Mr. Mitanshu Shah, Head Finance; and Mr. Ajay Kumar Desai, Senior VP, Finance. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. R.K. Baheti, Director Finance and CFO. Thank you, and over to you, sir.
Raj Kumar Shreeram Baheti - Alembic Pharmaceuticals Limited - Director of Finance, CFO & Executive Director
Thank you. Good evening, everyone. Thank you for joining the fourth quarter results, and of course, the annual organization's conference call. I'm sure you would have viewed our results. However, let me briefly take you through our numbers for the quarter ended 31st March 2021 and the year ended 31st March 2021. I'll start the financials.
During the quarter, our total revenue grew by 6% to INR 1,280 crores. EBITDA grew by 6% again to INR 359
Q4 2021 Alembic Pharmaceuticals Ltd Earnings Call Transcript
May 04, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers